300289.SZ

Beijing Leadman Biochemistry Co.,Ltd. 300289.SZ

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 300289.SZ 300326.SZ 603387.SS 002022.SZ 688298.SS 300318.SZ 300246.SZ 300314.SZ 688580.SS 300642.SZ
6M 69.98 % 2.06 % 2.14 % 22.26 % 12.79 % -15.93 % 33.33 % 17.11 % 19.59 % 102.96 %
YTD 59.42 % -7.03 % 1.00 % 8.57 % -10.66 % 2.52 % 33.54 % 29.00 % 76.12 % 92.58 %
1Y 56.50 % 15.76 % -1.82 % 6.12 % -19.09 % -3.23 % 18.19 % 12.71 % 73.27 % 80.13 %
3Y 22.61 % -25.63 % -40.19 % -50.89 % -63.29 % -13.51 % -11.93 % -2.83 % 9.20 % 18.10 %
5Y -4.23 % -72.14 % -60.80 % -66.93 % -74.20 % -72.28 % -63.65 % -31.05 % -60.92 % -18.94 %
10Y -53.61 % -51.04 % -2.76 % -72.22 % -70.78 % -44.15 % -52.27 % -62.45 % -73.39 % 38.96 %
From the beginning 16.67 % 35.84 % -2.76 % 298.85 % -70.78 % 94.20 % 7.46 % 69.68 % -73.39 % 38.96 %

Dividend

Beijing Leadman Biochemistry Co.,Ltd.

Shanghai Kinetic Medical Co., Ltd

Getein Biotech, Inc

Shanghai Kehua Bio-Engineering Co.,Ltd

Zhejiang Orient Gene Biotech Co., Ltd.

Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Guangdong Biolight Meditech Co., Ltd.

Ningbo David Medical Device Co., Ltd.

Nanjing Vishee Medical Technology Co., Ltd

Tellgen Corporation